Chittaranjan Locomotive Works(CLW), under the Ministry of Railways, Government of India desires to engage the following full time Para-medical Staff on contract basis for a duration up to 30-06-2016 or till availability of regularly selected candidates, whichever is earliest, through “WALK-IN-INTERVIEW”, on the terms and conditions stipulated in para-2 below -
GSK announced that the European Commission has approved a variation to expand the current therapeutic indication for Volibris® (ambrisentan) to include its use in combination treatment for patients with pulmonary arterial hypertension (PAH). Volibris is indicated for treatment of PAH in adult patients of WHO Functional Class (FC) II to III, including use in combination treatment.